Sirona Biochem Corp. (SRBCF)
OTCMKTS
· Delayed Price · Currency is USD
0.0186
0.00 (0.00%)
Apr 28, 2025, 4:00 PM EDT
Sirona Biochem Revenue
Sirona Biochem had revenue of 2.54K CAD in the quarter ending July 31, 2024, a decrease of -62.69%. This brings the company's revenue in the last twelve months to -16.36K, down -119.39% year-over-year. In the fiscal year ending October 31, 2023, Sirona Biochem had annual revenue of 34.78K, down -94.82%.
Revenue (ttm)
-16.36K CAD
Revenue Growth
-119.39%
P/S Ratio
-926.63
Revenue / Employee
n/a
Employees
n/a
Market Cap
10.98M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Oct 31, 2023 | 34.78K | -637.14K | -94.82% |
Oct 31, 2022 | 671.92K | 403.90K | 150.70% |
Oct 31, 2021 | 268.02K | 162.31K | 153.54% |
Oct 31, 2020 | 105.71K | -30.03K | -22.12% |
Oct 31, 2019 | 135.74K | -1.14M | -89.38% |
Oct 31, 2018 | Pro | Pro | Pro |
Oct 31, 2017 | Pro | Pro | Pro |
Oct 31, 2016 | Pro | Pro | Pro |
Oct 31, 2015 | Pro | Pro | Pro |
Oct 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Glass House Brands | 200.90M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Silence Therapeutics | 43.26M |
Sirona Biochem News
- 6 days ago - Sirona Biochem Announces Debenture Financing - GlobeNewsWire
- 7 days ago - Sirona Biochem Secures Strategic Investment Agreements and New Joint Venture with Promura GmbH - GlobeNewsWire
- 3 months ago - Sirona Biochem Showcases TFC-1326 in Stonegate Healthcare's Landmark Report - GlobeNewsWire
- 5 months ago - Sirona Biochem Announces Publication of Groundbreaking Study on TFC-1326 Compound in the Journal of Cosmetic Dermatology - GlobeNewsWire
- 7 months ago - SIRONA BIOCHEM Poised for Profitability in 2025 with Anti-Aging Product Rollout - GlobeNewsWire
- 11 months ago - GlycoProteMim Featured in Stonegate Healthcare's Latest Anti-Aging Research Report - GlobeNewsWire
- 1 year ago - SIRONA BIOCHEM Corporate Update April 2024 - GlobeNewsWire
- 1 year ago - Sirona Biochem Announces Close of Private Placement - GlobeNewsWire